A randomized, placebo-controlled trial of the benzoquinone idebenone in a mouse model of OPA1-related dominant optic atrophy reveals a limited therapeutic effect on retinal ganglion cell dendropathy and visual function
- Submitting institution
-
Cardiff University / Prifysgol Caerdydd
- Unit of assessment
- 3 - Allied Health Professions, Dentistry, Nursing and Pharmacy
- Output identifier
- 96214218
- Type
- D - Journal article
- DOI
-
10.1016/j.neuroscience.2016.01.042
- Title of journal
- Neuroscience
- Article number
- -
- First page
- 92
- Volume
- 319
- Issue
- -
- ISSN
- 0306-4522
- Open access status
- Out of scope for open access requirements
- Month of publication
- January
- Year of publication
- 2016
- URL
-
http://dx.doi.org/10.1016/j.neuroscience.2016.01.042
- Supplementary information
-
-
- Request cross-referral to
- -
- Output has been delayed by COVID-19
- No
- COVID-19 affected output statement
- -
- Forensic science
- No
- Criminology
- No
- Interdisciplinary
- No
- Number of additional authors
-
3
- Research group(s)
-
-
- Citation count
- 15
- Proposed double-weighted
- No
- Reserve for an output with double weighting
- No
- Additional information
-
- Author contribution statement
- -
- Non-English
- No
- English abstract
- -
